Enanta Pharmaceuticals
ENTA
#8066
Rank
$0.36 B
Marketcap
$12.60
Share price
-3.08%
Change (1 day)
66.23%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of March 2026 : $0.31 Billion USD

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are $0.31 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2026)

Total assets by year

Year Total assets Change
2025-09-30$0.28 B-25.47%
2024-09-30$0.37 B-18.52%
2023-09-30$0.46 B23.14%
2022-09-30$0.37 B-14.44%
2021-09-30$0.43 B-9.74%
2020-09-30$0.48 B-0.75%
2019-09-30$0.48 B18.25%
2018-09-30$0.41 B26.82%
2017-09-30$0.32 B16.13%
2016-09-30$0.28 B14.33%
2015-09-30$0.24 B58.29%
2014-09-30$0.15 B32.86%
2013-09-30$0.11 B124.25%
2012-09-30$52.16 M99.89%
2011-09-30$26.09 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
$200.89 B 63,735.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$118.53 B 37,564.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
$136.46 B 43,262.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$26.48 B 8,315.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$128.68 B 40,790.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$86.47 B 27,378.52%๐Ÿ‡บ๐Ÿ‡ธ USA